Cagrilintide

Limited humanfat_lossmetabolic

Community score3.50 reviews · 0 tracking

A long-acting amylin analog from Novo Nordisk in late-stage development, typically combined with semaglutide as CagriSema. Phase 2 data shows additive weight loss beyond semaglutide alone. Not yet approved.

For research and personal log purposes. peptidio does not sell, ship, prescribe, or endorse any peptide for the prevention, treatment, or cure of any condition.